COVID-19 Impact on Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: CF72B8E4224DEN
QYResearch

Abstracts

This report focuses on the global Peptide Receptor Radionuclide Therapy (PRRT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide Receptor Radionuclide Therapy (PRRT) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Novartis
• ITM Solucin
• National Institutes of Health
• Australasian Gastro-Intestinal Trials Group
• ...

Market segment by Type, the product can be split into

• Gastroenteropancreatic Neuroendocrine Tumor
• Foregut Neuroendocrine Tumor
• Midgut Neuroendocrine Tumor
• Hindgut Neuroendocrine Tumor

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Peptide Receptor Radionuclide Therapy (PRRT) status, future forecast, growth opportunity, key market and key players.
• To present the Peptide Receptor Radionuclide Therapy (PRRT) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Peptide Receptor Radionuclide Therapy (PRRT) are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peptide Receptor Radionuclide Therapy (PRRT) Revenue
1.4 Market Analysis by Type
  1.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Gastroenteropancreatic Neuroendocrine Tumor
  1.4.3 Foregut Neuroendocrine Tumor
  1.4.4 Midgut Neuroendocrine Tumor
  1.4.5 Hindgut Neuroendocrine Tumor
1.5 Market by Application
  1.5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Peptide Receptor Radionuclide Therapy (PRRT) Industry Impact
  1.6.1 How the Covid-19 is Affecting the Peptide Receptor Radionuclide Therapy (PRRT) Industry
    1.6.1.1 Peptide Receptor Radionuclide Therapy (PRRT) Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Peptide Receptor Radionuclide Therapy (PRRT) Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Peptide Receptor Radionuclide Therapy (PRRT) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Perspective (2015-2026)
2.2 Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Regions
  2.2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Share by Regions (2015-2020)
  2.2.3 Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Strategy
  2.3.6 Primary Interviews with Key Peptide Receptor Radionuclide Therapy (PRRT) Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Market Size
  3.1.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue (2015-2020)
  3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2015-2020)
  3.1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio
  3.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2019
3.3 Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Area Served
3.4 Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
3.5 Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Type (2015-2020)
4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2021-2026)

5 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)
5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
6.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in North America (2019-2020)
6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
6.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
7.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Europe (2019-2020)
7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
7.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

8 CHINA

8.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
8.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in China (2019-2020)
8.3 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
8.4 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
9.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Japan (2019-2020)
9.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
9.4 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
10.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
10.4 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

11 INDIA

11.1 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
11.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in India (2019-2020)
11.3 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
11.4 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
12.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Central & South America (2019-2020)
12.3 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
12.4 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novartis
  13.1.1 Novartis Company Details
  13.1.2 Novartis Business Overview and Its Total Revenue
  13.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Introduction
  13.1.4 Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020))
  13.1.5 Novartis Recent Development
13.2 ITM Solucin
  13.2.1 ITM Solucin Company Details
  13.2.2 ITM Solucin Business Overview and Its Total Revenue
  13.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Introduction
  13.2.4 ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
  13.2.5 ITM Solucin Recent Development
13.3 National Institutes of Health
  13.3.1 National Institutes of Health Company Details
  13.3.2 National Institutes of Health Business Overview and Its Total Revenue
  13.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Introduction
  13.3.4 National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
  13.3.5 National Institutes of Health Recent Development
13.4 Australasian Gastro-Intestinal Trials Group
  13.4.1 Australasian Gastro-Intestinal Trials Group Company Details
  13.4.2 Australasian Gastro-Intestinal Trials Group Business Overview and Its Total Revenue
  13.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Introduction
  13.4.4 Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
  13.4.5 Australasian Gastro-Intestinal Trials Group Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Peptide Receptor Radionuclide Therapy (PRRT) Key Market Segments
Table 2. Key Players Covered: Ranking by Peptide Receptor Radionuclide Therapy (PRRT) Revenue
Table 3. Ranking of Global Top Peptide Receptor Radionuclide Therapy (PRRT) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gastroenteropancreatic Neuroendocrine Tumor
Table 6. Key Players of Foregut Neuroendocrine Tumor
Table 7. Key Players of Midgut Neuroendocrine Tumor
Table 8. Key Players of Hindgut Neuroendocrine Tumor
Table 9. COVID-19 Impact Global Market: (Four Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Peptide Receptor Radionuclide Therapy (PRRT) Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Peptide Receptor Radionuclide Therapy (PRRT) Players to Combat Covid-19 Impact
Table 14. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions (2015-2020)
Table 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Strategy
Table 24. Main Points Interviewed from Key Peptide Receptor Radionuclide Therapy (PRRT) Players
Table 25. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2015-2020) (Million US$)
Table 26. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Players (2015-2020)
Table 27. Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2019)
Table 28. Global Peptide Receptor Radionuclide Therapy (PRRT) by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
Table 31. Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020) (Million US$)
Table 34. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Type (2015-2020)
Table 35. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2021-2026)
Table 36. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Application (2015-2020)
Table 37. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020) (Million US$)
Table 38. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Application (2021-2026)
Table 39. North America Key Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Peptide Receptor Radionuclide Therapy (PRRT) Market Share (2019-2020)
Table 41. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020) (Million US$)
Table 42. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2015-2020)
Table 43. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020) (Million US$)
Table 44. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2015-2020)
Table 45. Europe Key Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Peptide Receptor Radionuclide Therapy (PRRT) Market Share (2019-2020)
Table 47. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2015-2020)
Table 49. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2015-2020)
Table 51. China Key Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue (2019-2020) (Million US$)
Table 52. China Key Players Peptide Receptor Radionuclide Therapy (PRRT) Market Share (2019-2020)
Table 53. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020) (Million US$)
Table 54. China Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2015-2020)
Table 55. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020) (Million US$)
Table 56. China Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2015-2020)
Table 57. Japan Key Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Peptide Receptor Radionuclide Therapy (PRRT) Market Share (2019-2020)
Table 59. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2015-2020)
Table 61. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Peptide Receptor Radionuclide Therapy (PRRT) Market Share (2019-2020)
Table 65. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2015-2020)
Table 67. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2015-2020)
Table 69. India Key Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue (2019-2020) (Million US$)
Table 70. India Key Players Peptide Receptor Radionuclide Therapy (PRRT) Market Share (2019-2020)
Table 71. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020) (Million US$)
Table 72. India Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2015-2020)
Table 73. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020) (Million US$)
Table 74. India Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Peptide Receptor Radionuclide Therapy (PRRT) Market Share (2019-2020)
Table 77. Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2015-2020)
Table 79. Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2015-2020)
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. ITM Solucin Company Details
Table 87. ITM Solucin Business Overview
Table 88. ITM Solucin Product
Table 89. ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020) (Million US$)
Table 90. ITM Solucin Recent Development
Table 91. National Institutes of Health Company Details
Table 92. National Institutes of Health Business Overview
Table 93. National Institutes of Health Product
Table 94. National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020) (Million US$)
Table 95. National Institutes of Health Recent Development
Table 96. Australasian Gastro-Intestinal Trials Group Company Details
Table 97. Australasian Gastro-Intestinal Trials Group Business Overview
Table 98. Australasian Gastro-Intestinal Trials Group Product
Table 99. Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020) (Million US$)
Table 100. Australasian Gastro-Intestinal Trials Group Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type: 2020 VS 2026
Figure 2. Gastroenteropancreatic Neuroendocrine Tumor Features
Figure 3. Foregut Neuroendocrine Tumor Features
Figure 4. Midgut Neuroendocrine Tumor Features
Figure 5. Hindgut Neuroendocrine Tumor Features
Figure 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Peptide Receptor Radionuclide Therapy (PRRT) Report Years Considered
Figure 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions: 2020 VS 2026
Figure 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Players in 2019
Figure 16. Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2019
Figure 18. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
Figure 27. ITM Solucin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. ITM Solucin Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
Figure 29. National Institutes of Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. National Institutes of Health Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
Figure 31. Australasian Gastro-Intestinal Trials Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Australasian Gastro-Intestinal Trials Group Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed